ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation

He, Qi; Yang, Junzheng; Chen, Weijian; Pan, Zhaofeng; Chen, Baihao; Zeng, Jiaxu; Zhang, Nenling; Lin, Yuewei; Chen, Chuyi; Xiao, Jiacong; Li, Miao; Li, Shaocong; Wang, Haibin*; Chen, Peng*广州中医药大学; 1; 5
BMC Complementary Medicine and Therapies2024-1-8DOI: 10.1186/s12906-023-04332-x
22阅读
引用收藏
分享

摘要

BackgroundThere are accumulating type 2 diabetes patients who have osteoporosis simultaneously. More effective therapeutic strategies should be discovered. Biochanin A (BCA) has been indicated that can play a role in improving metabolic disorders of type 2 diabetes and preventing osteoporosis. But whether BCA can treat type 2 diabetic osteoporosis has not been studied.PurposeTo investigate if the BCA can protect against type 2 diabetic osteoporosis and clarify the mechanism.MethodsMicro-CT and histology assays were performed to detect the trabecular bone and analyze the bone histomorphology effect of BCA. CCK-8 assay was performed to detect the toxicity of BCA. TRAcP staining, immunofluorescence and hydroxyapatite resorption assay were used to observe osteoclasts differentiation and resorptive activity. Molecular docking provided evidence about BCA regulating the MAPK axis via prediction by the algorithm. QRT-PCR and Western Blotting were utilized to detect the expression of osteoclastogenesis-related markers and MAPK signaling pathway.ResultsAccumulation of bone volume after BCA treatment could be found based on the 3D reconstruction. Besides, there were fewer osteoclasts in db/db mice treated with BCA than db/db mice treated with saline. In vitro, we found that BCA hadn't toxicity in osteoclasts precursor, but also inhibited differentiation of osteoclasts. Further, we found that BCA suppresses osteoclastogenesis via ROS/MAPK signaling pathway.ConclusionBCA can prevent type 2 diabetic osteoporosis by restricting osteoclast differentiation via ROS/MAPK signaling pathway.

学科与关键词

关键词
Biochanin AType 2 diabetic osteoporosisOsteoclastsOxidative stressMAPK signaling pathway
相关
加载中…
  • Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody array
    Yang, Junzheng; He, Qi; Wang, Yunhan; Pan, Zhaofeng; Zhang, Gangyu; Liang, Jianming; Su, Lijun; Wang, Ailin; Zeng, Chuning; Luo, Haoran; Liu, Lingyun; Li, Jianliang; Rao, Qiuhong; Wang, Baohua*; Wang, Haibin*; Chen, Peng*PHYTOMEDICINE, 2022, 94: 153810.被引 10
  • A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
    Hong, Guoju; Chen, Zhenqiu; Han, Xiaorui; Zhou, Lin; Pang, Fengxiang; Wu, Rishana; Shen, Yingshan; He, Xiaoming; Hong, Zhinan; Li, Ziqi; He, Wei; Wei, Qiushi*Clinical and Translational Medicine, 2021, 11(5): e392.被引 31
  • Gegen Qinlian decoction ameliorates type 2 diabetic osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on Cytokine Antibody
    Yang, Junzheng; He, Qi; Pan, Zhaofeng; Chen, Peng
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC Complementary Medicine and Therapies
发表日期
2024-01-08
卷期
第 24 卷, 第 1 期
页码
24
DOI
10.1186/s12906-023-04332-x
成果收录
SCIE
资助标注
National Natural Science Foundation of China

作者

  • H

    He, Qi (第一作者)

    1 · guangzhou univ chinese med

  • Y

    Yang, Junzheng

    5 · guangzhou univ chinese med

查看全部 14 位作者收起作者
  • C

    Chen, Weijian

    5 · guangzhou univ chinese med

  • P

    Pan, Zhaofeng

    1 · guangzhou univ chinese med

  • C

    Chen, Baihao

    guangzhou univ chinese med · 1

  • Z

    Zeng, Jiaxu

    1 · guangzhou univ chinese med

  • Z

    Zhang, Nenling

  • L

    Lin, Yuewei

    guangzhou univ chinese med · 1

  • C

    Chen, Chuyi

    1 · guangzhou univ chinese med

  • X

    Xiao, Jiacong

    guangzhou univ chinese med · 1

  • L

    Li, Miao

    1 · guangzhou univ chinese med

  • L

    Li, Shaocong

    guangzhou univ chinese med · 1

  • W

    Wang, Haibin (通讯)

    1 · guangzhou univ chinese med

  • C

    Chen, Peng (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417